---
title: "Endava plc Stock 12‑Month Price Target Cut to $5.26, Implies 63% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288132690.md"
description: "Endava plc's average 12-month price target was cut from $6.08 to $5.26 by analysts, implying a 63% upside based on the May 29 closing price. The consensus rating shifted to 'Hold' among nine covering analysts, comprising three buys, five holds, and one sell."
datetime: "2026-05-30T04:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288132690.md)
  - [en](https://longbridge.com/en/news/288132690.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288132690.md)
generator: "portal-rs"
---

# Endava plc Stock 12‑Month Price Target Cut to $5.26, Implies 63% Upside

-   According to estimates from 6 analysts, Endava plc stock's average price target has fallen from $6.08 to $5.26, with forecasts ranging from $3.5 to $10.01 per share
-   Based on the May 29 closing price, the updated target implies approximately 63% potential upside
-   Consensus rating has shifted to “Hold” across 9 covering analysts, with 3 Buys, 5 Holds and 1 Sells

Explore more price target data and ratings for Endava plc on the , and track all previous and future analyst recommendations for Endava plc in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [DAVA.US](https://longbridge.com/en/quote/DAVA.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Endava Analysts Slash Their Forecasts Following Downbeat Q3 Results](https://longbridge.com/en/news/287396556.md)
- [Endava plc Stock 12‑Month Price Target Cut to $8.28, Implies 107% Upside](https://longbridge.com/en/news/287263782.md)
- [Should White Mountains (WTM) Investors React to Strong Q2 Earnings and a Major Share Buyback?](https://longbridge.com/en/news/296004368.md)
- [Darden Restaurants Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/296087757.md)
- [Should FDA Clearance Of QIAstat-Dx Sepsis Panel Require Action From Qiagen (QGEN) Investors?](https://longbridge.com/en/news/296027748.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**